Long COVID Evaluation in Beverly Hills & Los Angeles
Months after the infection cleared, the symptoms didn’t. The fatigue, the brain fog, the racing heart when you stand, the body-wide pain a normal workup can’t explain — these are not in your head. At The Fascia Institute and Treatment Center® of LA, a physician-led Long COVID evaluation looks for the musculoskeletal, fascial, metabolic, and connective-tissue drivers that standard post-COVID visits routinely miss — then treats them.
Seen in-clinic in Beverly Hills — or by remote visit if you’re based anywhere in California. And because every case is different, your evaluation and plan are built around your symptoms, not a template.
What Long COVID can look like
Long COVID — the post-acute symptoms that linger weeks, months, or years after a SARS-CoV-2 infection — can touch nearly every system in the body. The U.S. CDC and the NIH RECOVER initiative recognize a wide and shifting symptom set. The clusters we see most often at FIT LA are the ones with a physical, examinable basis:
If a chest X-ray, an ECG, and routine labs all came back “normal” while you still feel broken, you are not imagining it. It often means the workup hasn’t yet looked at the tissue that connects everything together — your fascia and connective tissue.
The connective-tissue link most workups miss
For a subset of patients, Long COVID doesn’t fully resolve because it sits on top of an underlying connective-tissue difference that was there all along — and was never diagnosed. Our founder, Dr. Jacques Courseault, MD, co-authored peer-reviewed research making exactly this case: that intractable Long COVID can be a signal of underlying hypermobile Ehlers-Danlos syndrome (hEDS) or hypermobility spectrum disorder (HSD).
The overlap is striking. Fatigue, post-exertional malaise, widespread pain, brain fog, and dysautonomia / POTS are core features of hypermobility as much as they are of Long COVID — and independent research has found hypermobility in a large share of patients with ME/CFS, fibromyalgia, POTS, and Long COVID. There is also a proposed mechanism at the tissue level: that the same fascial myofibroblasts driving “viral fibromyalgia-ness” may help explain the stubborn, body-wide pain.
Yang M, Logarbo B, Courseault J, et al. “Long COVID and the diagnosis of underlying hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.” PM&R (2024). The work asked whether the hardest-to-treat Long COVID cases were, in fact, undiagnosed hypermobility — and argued the two share a common thread. Read the paper (PM&R / Wiley) · PubMed PMID 38116712.
Why this matters for you: a hypermobility-aware, fascia-aware evaluation can surface a driver that’s both testable and treatable — turning an open-ended “Long COVID” label into a concrete plan. That is the entire premise of how we evaluate at FIT LA.
“Hypermobility is not rare. Hypermobility is like a Ferrari that requires a lot of maintenance and the best synthetic oil.”
— Dr. Jacques Courseault, MD, CAQSM, FAAPMR
What a Long COVID evaluation at FIT LA includes
This is not a 12-minute “everything looks normal” visit. It is a structured, physician-led assessment built to find the physical and connective-tissue contributors to your symptoms — and to give you a plan.
When it started, what triggers crashes, and how fatigue, pain, cognition, and heart-rate symptoms cluster — the pattern often points to the driver.
Our head-to-toe diagnostic images the fascia and soft tissue to locate the restrictions and dysfunction driving body-wide pain. See how Fascial Mapping® works →
A Beighton score and connective-tissue assessment to check for the underlying hEDS / HSD that intractable Long COVID can unmask. Our hypermobility & EDS program →
Bloodwork and inflammatory markers, metabolic panels, and metabolic-genetics testing — including the MTHFR / folate & methylation pathway central to Dr. Courseault’s hypermobility research — to uncover treatable drivers of fatigue, pain, and inflammation. Explore FIT GPS genomic screening →
Screening for orthostatic and POTS-type symptoms — the racing heart, lightheadedness, and exercise intolerance that so often travel with Long COVID and hypermobility.
Findings explained in plain language, then a sequenced plan that doesn’t stop at the diagnosis — treatment now, plus the long-term maintenance that keeps you well. Not another shrug.
We don’t stop at answers — we treat, and we keep treating
A diagnosis you can’t act on isn’t worth much. FIT LA doesn’t claim to “cure” Long COVID — no one honestly can — but we don’t stop at naming the problem either. We treat the contributing musculoskeletal, fascial, metabolic, and inflammatory drivers, and we stay with you for the long-term maintenance that keeps hard-won gains from slipping away. Depending on your findings, your plan may combine:
Long COVID rarely lives in one specialty. Most patients get passed between siloed clinics — cardiology, rheumatology, neurology, physical therapy — each treating a fragment. At FIT LA, fascia, metabolism, genetics, autonomic symptoms, inflammation, and reconditioning are evaluated and treated together, by one physician-led team that reads them as a single connected picture.
If screening points to hypermobility, you move into our structured Hypermobility & EDS program — the same physician-led pathway pioneered at our New Orleans flagship. And because Long COVID recovery is rarely linear, we build in ongoing follow-up and maintenance — adjusting medications, modalities, and metabolic support as you change — rather than discharging you with a one-time list.
Evaluated by the physician who published the research
Many clinics borrow the word “fascia.” Dr. Jacques Courseault, MD, CAQSM, FAAPMR built the field around it. Board-certified in Physical Medicine & Rehabilitation with a Certificate of Added Qualification in Sports Medicine and an Assistant Professor at Tulane, he is the founder of The Fascia Institute and Treatment Center® — and a co-author of the peer-reviewed research connecting Long COVID to underlying hypermobility.
The Institute’s flagship in New Orleans is one of the first clinics in the world built specifically for hypermobility and Ehlers-Danlos syndrome. You can review the full research and publication record, the Fascia Institute itself, its Hypermobility & EDS Clinic, and the folate-dependent hypermobility work — then bring that same expertise to your case here in Beverly Hills.
PM&R · CAQ Sports Medicine
Founder, The Fascia Institute®
Asst. Professor, Tulane SOM
Castle Connolly Top Doctor
Long COVID evaluation FAQ
Your Long COVID symptoms deserve a real evaluation
If you’ve spent months being told everything is “normal,” book the evaluation built to look deeper. Same expertise that put fascia and hypermobility medicine on the map — now in Beverly Hills.
In-clinic in Beverly Hills — remote visits available for California residents.
The Fascia Institute and Treatment Center® of LA · 415 North Crescent Drive, Suite 130, Beverly Hills, CA 90210 · (424) 378-3488 · fit@fasciala.com
- Yang M, Logarbo B, Courseault J, Wickramasuriya N, Bix G, Longo M. “Long COVID and the diagnosis of underlying hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders.” PM&R. 2024. PMID 38116712 · doi:10.1002/pmrj.13120.
- Courseault J, Kingry C, Morrison V, et al. “Folate-dependent hypermobility syndrome: A proposed mechanism and diagnosis.” Heliyon. 2023. PMC10122021.
- Courseault J, et al. “Prevalence of MTHFR polymorphisms in hEDS & HSD patients.” ACR Open Rheumatology. 2024. doi:10.1002/acr2.11667.
- Ganesh R, Munipalli B. “Long COVID and hypermobility spectrum disorders have shared pathophysiology.” Frontiers in Neurology. 2024. PMC11410636.
- “‘Long COVID-19’ and viral ‘fibromyalgia-ness’: Suggesting a mechanistic role for fascial myofibroblasts.” 2023. PMC10117846.
- CDC. “Long COVID Signs and Symptoms.” cdc.gov/long-covid.
- NIH RECOVER Initiative. recovercovid.org.
This page is for general education and is not a substitute for individualized medical advice, diagnosis, or treatment. Every case is different: an evaluation does not guarantee a specific diagnosis or outcome, and results vary from person to person. Always consult a qualified clinician about your symptoms.


